A globally occurring indel polymorphism in the promoter of the IFNA2 gene is not associated with severity of malaria but with the positivity rate of HCV

BMC Genet. 2008 Dec 3;9:80. doi: 10.1186/1471-2156-9-80.

Abstract

Background: Type I Interferons (IFNs) are well known cytokines which exert antiviral activity, antitumor activity and immunomodulatory effects. Single-nucleotide polymorphisms (SNP) and deletions in the gene coding for IFNA2 have been shown to influence the level of expression in vitro. The indel polymorphism -305_-300delAACTTT showed the strongest effect in vitro. To analyse the worldwide distribution of this polymorphism we analyzed five different populations (586 Vietnamese, 199 Central Africans, 265 Brazilians, 108 Kaingang and 98 Guarani). To investigate a possible association with susceptibility to infectious diseases we determined the polymorphism in malaria patients suffering either mild or severe malaria and in a cohort of hepatitis C virus infected individuals.

Results: We could detect the indel polymorphism in all populations analysed. There was no association with this polymorphism and the outcome of malaria but we found an increase of this indel polymorphism in hepatitis C virus positive individuals compared to healthy controls (p = 0.014).

Conclusion: Polymorphisms in genes involved in the interferon pathway have been implicated in the resistance or susceptibility against cerebral malaria and HBV. Here we show that an indel polymorphism, which mediates a disadvantageous effect in HBV patients, may also play a disadvantageous role in HCV infections stressing the importance of a fully functional interferon pathway.

MeSH terms

  • Alleles
  • Gene Frequency
  • Genetic Predisposition to Disease*
  • Genotype
  • Hepacivirus / genetics*
  • Humans
  • Interferon-alpha / genetics*
  • Linkage Disequilibrium
  • Malaria / genetics
  • Malaria / pathology*
  • Polymorphism, Genetic*
  • Promoter Regions, Genetic / genetics*
  • Sequence Deletion*

Substances

  • Interferon-alpha